This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Montréal directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $4,986,431
Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial
CIHR · 2022 · Principal investigator
Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial
Principal investigators: Jutras-Aswad, Didier; de Kiewit, Alexandra; Bach, Paxton J; Bruneau, Julie; Davidson, Sara; Emerson, Yvette; Hodgins, David C; Le Foll, Bernard; Poulin, Ginette; Rehm, Jürgen T; Stewart, Sherry H; Wood, Evan
Keywords: Addiction; Agonist Therapy; Contingency Management; High Dose Stimulant; Mental Health; Methamphetamine; Randomized Clinical Trial
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.